Fortive
Builds instrumentation, facility software, safety tools, and healthcare workflow systems.
Something off on this page? Send us feedback.
Profile
Sells professional instruments, facility and asset software, worker-safety tools, and healthcare sterilization, tracking, testing, and clinical-workflow systems. Revenue spans products, software, services, and sterilization consumables across two segments, with demand anchored in maintenance, compliance, and regulated healthcare procedures.
Equips industrial and facilities teams with Fluke professional instruments, Accruent, ServiceChannel, and Gordian asset-lifecycle software, and Industrial Scientific and Intelex safety and compliance tools. These offerings form Intelligent Operating Solutions, serving maintenance, utilities, manufacturing and other mission-critical workflows.
Supplies healthcare providers through Advanced Healthcare Solutions: ASP sterilization systems, Censis instrument tracking, Provation clinical productivity software, and Fluke Biomedical and Landauer testing and radiation-safety tools. The portfolio spans products, software and services across roughly 50 countries.
Applies the Fortive Business System through a shared operating cadence and continuous-improvement tools across its businesses. Demand is tied to facility upkeep, industrial safety and healthcare procedures; medical devices face extensive U.S. and international approval, manufacturing and post-market requirements.
Company facts
Key statistics
Year to date +7.8% · Average volume (30d) 2.5M
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Jul 2, 2026 | Truist Financial | Target | $61 | $67 | ||
| Jun 3, 2026 | Morgan Stanley | Reiterate | Equal Weight | $89 | $59 | |
| May 11, 2026 | Argus Research | Upgrade | Hold | Buy | $85 | $68 |
| May 4, 2026 | Truist Financial | Target | $56 | $61 | ||
| Apr 20, 2026 | Truist Financial | Target | $58 | $56 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Jul 29, 2026Q2 FY26 | $0.71 | $0.74 | +4.7% | $1.07B | $1.10B | +2.6% | −7.10% |
| Apr 30, 2026Q1 FY26 | $0.64 | $0.70 | +8.9% | $1.04B | $1.07B | +3.0% | −1.27% |
| Feb 4, 2026Q4 FY25 | $0.84 | $0.90 | +7.4% | $1.09B | $1.12B | +2.6% | +0.12% |
| Oct 29, 2025Q3 FY25 | $0.57 | $0.68 | +19.5% | $1.01B | $1.03B | +1.9% | +1.81% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $1.47B | $1.52B | $1.03B | $1.12B | $1.07B | $1.10B | |
| Gross profit | $880.9M | $895.7M | $649.2M | $708.9M | $675.5M | $695.3M | |
| Operating income | $260.6M | $263.2M | $159.6M | $225.5M | $191.7M | $209.9M | |
| Net income | $171.9M | $166.6M | $55.0M | $185.7M | $136.4M | $157.3M | |
| Diluted EPS | $0.50 | $0.49 | $0.17 | $0.58 | $0.44 | $0.51 | |
| Gross margin | 59.8% | 59.0% | 63.2% | 63.2% | 63.2% | 63.4% | |
| Operating margin | 17.7% | 17.3% | 15.5% | 20.1% | 17.9% | 19.1% |
Fiscal years (4-quarter sums)FY21 $5.25B · FY22 $5.83B · FY23 $6.07B · FY24 $6.23B · FY25 $5.14B
Revenue by product · Q2 FY26
Revenue by geography · FY24
Balance sheet, Jul 3, 2026Cash & short-term investments $374.2M · Total debt $3.51B · Total assets $11.62B · Shareholders' equity $6.06B
Dividends
Raised for 8 straight years. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Jun 22, 2026 | Jun 22 | Jul 6 | $0.06 | |
| Mar 13, 2026 | Mar 13 | Mar 27 | $0.06 | |
| Nov 28, 2025 | Nov 28 | Dec 26 | $0.06 | |
| Sep 12, 2025 | Sep 12 | Sep 26 | $0.06 | cut from $0.0603 split-adjusted |
| May 30, 2025 | May 30 | Jun 27 | $0.08 | |
| Feb 28, 2025 | Feb 28 | Mar 28 | $0.08 | |
| Nov 29, 2024 | Nov 29 | Dec 27 | $0.08 | |
| Sep 13, 2024 | Sep 13 | Sep 27 | $0.08 |
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 302.02M · Float 277.69M · 92.0% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Dodge & Cox | 43.98M | 14.56% | 13F | Aug 13, 2026 |
| BlackRock, Inc. | 26.62M | 8.82% | 13F | Aug 7, 2026 |
| Price T Rowe Associates Inc /MD/ | 24.38M | 8.07% | 13F | Aug 14, 2026 |
| T. Rowe Price Associates, Inc. | 23.75M | 7.70% | 13G | May 15, 2026 |
| Vanguard Capital Management LLC | 19.94M | 6.60% | 13F | Aug 13, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 10, 2026 | Peter C. Underwood | officer: SVP - Chief Legal Officer | −8,662 | $61.59 |
| May 4, 2026 | Peter C. Underwood | officer: SVP - Chief Legal Officer | −47,557 | $60.81 |
| Feb 18, 2026 | Kate Mitchell | director | −7,131 | $58.34 |
| Nov 10, 2025 | Peter C. Underwood | officer: SVP - Chief Legal Officer | −58,133 | $51.28 |
| Oct 31, 2025 | Stacey A. Walker | officer: SVP - Chief People Officer | −2,192 | $50.35 |
Peers
- STERIS
Sterile processing and sterilization overlap AHS
- Honeywell Technologies
Industrial safety and gas-detection overlap in IOS
- ServiceNow
Cloud workflow platform overlaps facilities and asset SaaS
- Emerson Electric
Plant reliability and measurement overlap in IOS
- IBM
Maximo contests asset lifecycle and reliability software
- MSA
Focused gas detection and connected-work safety peer
- Mirion Technologies
Radiation monitoring and dosimetry overlap AHS
- Autodesk
Construction-cost workflows overlap Gordian
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Fortive | $59.69 | 0.00% | $18.03B | 35.1 | 19.2 | 4.2 | −27.8% |
| STERIS | $233.78 | +0.06% | $22.78B | 28.6 | 20.4 | 3.8 | +7.8% |
| Honeywell Technologies | $217.85 | +0.18% | $68.91B | 8.4 | 23.7 | 1.9 | −49.9% |
| ServiceNow | $143.28 | −0.97% | $149.61B | 90.4 | 31.9 | 10.2 | +24.0% |
| Emerson Electric | $156.00 | +0.53% | $86.93B | 34.0 | 22.0 | 4.7 | +7.0% |
| IBM | $235.80 | +0.10% | $221.96B | 20.8 | 18.4 | 3.2 | +1.1% |
| MSA | $190.34 | −0.04% | $7.35B | 23.7 | 19.8 | 3.8 | +6.2% |
| Mirion Technologies | $14.66 | +2.02% | $3.50B | 153.8 | 24.5 | 3.4 | +19.7% |
| Autodesk | $260.19 | −0.22% | $55.04B | 33.8 | 19.7 | 7.1 | +16.1% |
| Median | 31.2 | 21.2 | 3.8 | +7.4% |